• Title/Summary/Keyword: disease rates

Search Result 1,896, Processing Time 0.025 seconds

Prevalence of Bordetella bronchiseptica, Mycoplasma felis, and Chlamydia felis using a newly developed triplex real-time polymerase chain reaction assay in Korean cat population

  • Hye-Ryung, Kim;Gyu-Tae, Jeon;Jong-Min, Kim;Ji-Su, Baek;Yeun-Kyung, Shin;Oh-Kyu, Kwon;Hae-Eun, Kang;Ho-Seong, Cho;Doo-Sung, Cheon;Choi-Kyu, Park
    • Korean Journal of Veterinary Service
    • /
    • v.45 no.4
    • /
    • pp.305-316
    • /
    • 2022
  • Bordetella (B.) bronchiseptica, Mycoplasma (M.) felis, and Chlamydia (C.) felis are considered as main bacterial pathogens of feline upper respiratory tract disease (URTD). In this study, a new triplex quantitative real-time polymerase chain reaction (tqPCR) assay was developed for the rapid and differential detection of these bacteria in a single reaction. The assay specifically amplified three bacterial genes with the detection limit of below 10 copies/reaction. The assay showed high repeatability and reproducibility, with coefficients of intra-assay and inter-assay variation of less than 1%. Based on the diagnostic results of the assay using 94 clinical samples obtained from cats with URTD signs, prevalence of B. bronchiseptica, M. felis, or C. felis was 10.6%, 36.2%, or 6.4%, respectively, indicating that the diagnostic sensitivity was comparable to those of previously reported monoplex qPCR assays. The dual infection rates for B. bronchiseptica and M. felis or M. felis and C. felis was 2.1% or 3.2%, respectively. These results indicated that M. felis has been widely spread, and its co-infection with B. bronchiseptica or M. felis has been frequently occurred in Korean cat population. The developed tqPCR assay will serve as a promising tool for etiological and epidemiological studies of these three bacterial pathogens and the prevalence data obtained in this study will contribute to expanding knowledge about the epidemiology of feline URTD in Korea.

Factors Affecting High Mortality Rates of Dairy Replacement Calves and Heifers in the Tropics and Strategies for Their Reduction

  • Moran, John B.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • v.24 no.9
    • /
    • pp.1318-1328
    • /
    • 2011
  • The tropics is not an ideal location for calf rearing as the high temperatures and humidities introduce many potential disease problems to milk fed calves. In addition, the type of dairy farming (generally poorly resourced small holder farming) and the general lack of awareness of the long term implications of poorly reared stock do not encourage farmers to pay close attention to their calf and heifer rearing systems. Surveys of calf rearing systems in Asia, tropical Africa and South America highlight the high calf and heifer mortalities. A range of 15 to 25% pre-weaning calf mortality is typical on many tropical dairy farms. It is often as high as 50%, indicating very poor calf management. This contrasts with US findings of less than 8% mortality from birth to 6 months while surveys of Australian farmers report only 3% losses. Simple extension programs on farms in Sri Lanka and Kenya have drastically reduced calf mortalities and improved pre-weaning growth rates. Improved management strategies leading to lower calving intervals, higher calving rates, reduced still born and pre-weaned calf mortalities and fewer non pregnant heifers can supply many more dairy herd replacements than currently occurs. Such strategies can increase the number of replacement heifer calves in the herd from 15 to over 35%, thus allowing farmers to increase their herd sizes through natural increases. Simple management procedures such as ensuring adequate intake of good quality colostrum within the first 12 hours of life, housing and good hygiene to minimise disease transfer, providing clean drinking water, developing appropriate feeding protocols to encourage early rumen development and paying closer attention to climate control and animal health can all lead to improved calf vigour and performance. Good record keeping is also important so farmers can more easily identify susceptible calves and quickly treat potential problems.

A study on the role of the school health teacher in school vaccination (학교 예방접종에 관한 논고)

  • Kim, Young-Im
    • Research in Community and Public Health Nursing
    • /
    • v.6 no.1
    • /
    • pp.74-83
    • /
    • 1995
  • Promotion of immunization including early recognition of disease symptoms and effective control of communicable disease have been the important role of the school heath teacher in Korea. The school heath teacher as a nurse have been practiced vaccination for students as one of the major method for promotion of immunization in school. Recently it was occured difficulty for school vaccination that is practicing by school health teacher. So it is predicted for reducing of vaccination coverage rates of students. The objectives of this study are, first; to examine current guidlines of government, second, to analysis problem according to current guidline, third, to discuss further direction for school vaccination. There are used study methods as litrature review, analysis of statistical data and case study etc. Analytical framework for increased effects of vaccination in this study was safty, cost -effectiveness and coverage rates of vaccination. Major suggestions are as follows : First, It is different from the role of the public and private sectors in preventive health services. The preventive health services are characterized that the effect of health promotion is large, but the period of input effect is slow. Therefore the leading role of school vaccination should be have school and school health teacher including public sectors. Second, Health management of contemporary people can be effective with cooperative relationship between various health manpower. School health teacher as a medical manpower should be provide vaccination service continiously for health promotion of students. Third, It is necessary to maintain collective vaccination in school because have lots of advantage at safty, cost-effectiveness and coverage rates. In conclusion, school heath teacher should have central and independent role in school vaccination in according to current law. Also it will be assured lawful compensation in prepare to accident in vaccination.

  • PDF

Experience with Pediatric Kidney Transplantation, 1985-2016: A Single Regional Center Study

  • Min, So Yoon;Jo, Tae Kyoung;Baek, Hee Sun;Park, Sook-Hyun;Kim, Hyung-Kee;Huh, Seung;Cho, Min Hyun
    • Childhood Kidney Diseases
    • /
    • v.21 no.2
    • /
    • pp.69-74
    • /
    • 2017
  • Purpose: Kidney transplantation (KT) is an ideal treatment for pediatric patients with end-stage renal disease (ESRD). We report the clinical outcomes of pediatric ESRD patients who underwent KT in a single regional center. Methods: We retrospectively investigated the medical records of 60 pediatric patients who were diagnosed with ESRD and underwent KT in our hospital between January 1985 and June 2016. Results: A total of 60 children and adolescents (40 male, 20 female; mean age, $13.86{\pm}4.26$ years) were included in this study. Six patients (10.0%) underwent KT immediately after receiving the diagnosis of ESRD, while the others underwent KT after dialysis treatment (mean period of dialysis, $368.7{\pm}4,41.8$ days). The mean donor age (50 living-related [83.3%], 10 deceased [16.7%]) was $40.0{\pm}12.85$ years and the male:female ratio was 1.07:1. The most common cause of ESRD was chronic glomerulonephritis. The overall survival rates at 1, 3, and 5 years after KT were 98%, 98%, and 96%, respectively, while the graft survival rates at 1, 3, and 5 years were 93%, 86%, and 68%, respectively. Children who underwent KT before 10 years of age had better monthly growth rates than those who underwent KT later than 10 years of age. Conclusions: KT is performed less frequently in children than in adults, but causes of ESRD vary and clinical outcomes after KT greatly affect the growth and development of pediatric patients. Therefore, further analysis and monitoring of clinical progression after KT in pediatric ESRD patients are necessary.

The Effectiveness of Additional Treatment Modalities after the Failure of Recanalization by Thrombectomy Alone in Acute Vertebrobasilar Arterial Occlusion

  • Kim, Seong Mook;Sohn, Sung-Il;Hong, Jeong-Ho;Chang, Hyuk-Won;Lee, Chang-Young;Kim, Chang-Hyun
    • Journal of Korean Neurosurgical Society
    • /
    • v.58 no.5
    • /
    • pp.419-425
    • /
    • 2015
  • Objective : Acute vertebrobasilar artery occlusion (AVBAO) is a devastating disease with a high mortality rate. One of the most important factors affecting favorable clinical outcome is early recanalization. Mechanical thrombectomy is an emerging treatment strategy for achieving a high recanalization rates. However, thrombectomy alone can be insufficient to complete recanalization, especially for acute stroke involving large artery atheromatous disease. The purpose of this study is to investigate the safety and efficacy of mechanical thrombectomy in AVBAO. Methods : Fourteen consecutive patients with AVBAO were treated with mechanical thrombectomy. Additional multimodal treatments were intra-arterial (IA) thrombolysis, balloon angioplasty, or permanent stent placement. Recanalization by thrombectomy alone and multimodal treatments were assessed by the Thrombolysis in Cerebral Infarction (TICI) score. Clinical outcome was determined using the National Institutes of Health Stroke Scale (NIHSS) at 7 days and the modified Rankin Scale (mRS) at 3 months. Results : Thrombectomy alone and multimodal treatments were performed in 10 patients (71.4%) and 4 patients (28.6%), respectively. Successful recanalization (TICI 2b-3) was achieved in 11 (78.6%). Among these 11 patients, 3 (27.3%) underwent multimodal treatment due to underlying atherosclerotic stenosis. Ten (71.4%) of the 14 showed NIHSS score improvement of >10. Overall mortality was 3 (21.4%) of 14. Conclusion : We suggest that mechanical thrombectomy is safe and effective for improving recanalization rates in AVBAO, with low complication rates. Also, in carefully selected patients after the failure of recanalization by thrombectomy alone, additional multimodal treatment such as IA thrombolysis, balloons, or stents can be needed to achieve successful recanalization.

Survival Analysis in Advanced Non Small Cell Lung Cancer Treated with Platinum Based Chemotherapy in Combination with Paclitaxel, Gemcitabine and Etoposide

  • Natukula, Kirmani;Jamil, Kaiser;Pingali, Usha Rani;Attili, Venkata Satya Suresh;Madireddy, Umamaheshwar Rao Naidu
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.8
    • /
    • pp.4661-4666
    • /
    • 2013
  • Background: The wide spectrum of clinical features in advanced stages of non-small cell lung cancer (NSCLC) probably contributes to disparities in outcomes because of different prognostic variables significant for stage IIIB/IV patients. Hence the aim of this study was to check for favorable response of patients to various chemotherapeutic combinations with respect to patient survival in stage IIIB and stage IV NSCLC disease. We selected those patients for our study who were receiving treatment with paclitaxel, gemcitabine or etoposide in combination with platinum based drugs. Materials and Methods: Seventy-two patients who visited the hospital from June 2009 to November 2012 with confirmed diagnosis of lung cancer were included, and data were collected for follow up and classified according to treatment received with respect to patients' regimen and response, and overall survival. This study analyzed tumor variables that were associated with clinical outcome in advanced NSCLC patients who were undergoing first-line chemotherapy for stage IIIB/IV NSCLC. Results: Comparative data on various parameters like age, gender, stage, histology, site of disease, metastatic site and chemo-regimens was analyzed; these parameters predicted variable significant improvement for overall survival ($p{\geq}0.05$). One and two year survival rates were 20.8% and 15.3%. Conclusions: In this study we found slight improvement in survival rates in NSCLC and clinical outcomes with one combination (carboplatin+paclitaxel). Overall there were only marginal differences in survival rates for other chemo-regimens evaluated in this study.

Survival Rate of Breast Cancer Patients In Malaysia: A Population-based Study

  • Abdullah, Nor Aini;Mahiyuddin, Wan Rozita Wan;Muhammad, Nor Asiah;Ali, Zainudin Mohamad;Ibrahim, Lailanor;Tamim, Nor Saleha Ibrahim;Mustafa, Amal Nasir;Kamaluddin, Muhammad Amir
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.8
    • /
    • pp.4591-4594
    • /
    • 2013
  • Breast cancer is the most common cancer among Malaysian women. Other than hospital-based results, there are no documented population-based survival rates of Malaysian women for breast cancers. This populationbased retrospective cohort study was therefore conducted. Data were obtained from Health Informatics Centre, Ministry of Health Malaysia, National Cancer Registry and National Registration Department for the period from $1^{st}$ January 2000 to $31^{st}$ December 2005. Cases were captured by ICD-10 and linked to death certificates to identify the status. Only complete data were analysed. Survival time was calculated from the estimated date of diagnosis to the date of death or date of loss to follow-up. Observed survival rates were estimated by Kaplan-Meier method using SPSS Statistical Software version 17. A total of 10,230 complete data sets were analysed. The mean age at diagnosis was 50.6 years old. The overall 5-year survival rate was 49% with median survival time of 68.1 months. Indian women had a higher survival rate of 54% compared to Chinese women (49%) and Malays (45%). The overall 5-year survival rate of breast cancer patient among Malaysian women was still low for the cohort of 2000 to 2005 as compared to survival rates in developed nations. Therefore, it is necessary to enhance the strategies for early detection and intervention.

Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer

  • Yang, Kyungmi;Park, Won;Huh, Seung Jae;Bae, Duk-Soo;Kim, Byoung-Gie;Lee, Jeong-Won
    • Radiation Oncology Journal
    • /
    • v.35 no.1
    • /
    • pp.39-47
    • /
    • 2017
  • Purpose: The purpose of this study was to analyze clinical outcomes from cervical cancer and stratify patients into risk groups for prognostic factors for early-stage disease. Materials and Methods: We retrospectively reviewed patients with stage IB or IIA cervical cancer treated with adjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) following primary surgery at Samsung Medical Center from 2001 to 2011. Adjuvant RT was added for patients with intermediate-risk factors, and adjuvant CCRT was performed on high-risk patients after surgery. Results: We reviewed 247 patients-149 in the high-risk group and 98 in intermediate-risk group. The median follow-up was 62 months. Loco-regional failure (LRF) alone occurred in 7 patients (2.8%), distant metastasis alone in 37 patients (15.0%) and LRF with DM in 4 patients (1.6%). The 5-year disease-free survival (DFS) and overall survival (OS) rates for both groups were 79.7% and 87.6%, respectively. In the high-risk group, the 5-year DFS and OS probabilities were 72.5% and 81.9%, respectively. Histologic type, pathologic tumor size, and the number of pelvic lymph node (PLN) metastasis were significant prognostic factors for DFS and OS. We suggest a scoring system (0-3) using these prognostic factors to predict poor prognosis in high-risk patients. Using this system, patients with higher scores have higher recurrence and lower survival rates. Conclusion: In the high-risk cervical-cancer group who received primary surgery and adjuvant CCRT, non-squamous type, large tumor size and the number of PLN metastasis were significant prognostic factors, and the number of these factors was associated with survival rates.

Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (비인강암의 동시 항암화학방사선치료)

  • Chung, Eun-Ji;Kim, Yong-Tai;Hong, Hyun-Jun;Hong, Won-Pyo
    • Korean Journal of Head & Neck Oncology
    • /
    • v.24 no.2
    • /
    • pp.169-173
    • /
    • 2008
  • Purpose:This is a retrospective study to evaluate the results of concurrent chemoradiotherapy in nasopharyngeal carcinoma. Material and Methods:From Mar 2000 to June 2005, 18 patients with nasopharyngeal carcinoma completed planned concurrent chemoradiotherapy. Stages were I in 1 patients, II in 2 patients, III in 7 patients and IV in 8 patients. Pathologic type was squamous cell carcinoma(WHO type 1) in 2 patients, non-keratinizing type(WHO type 2) in 8 patients and undifferetiated carcinoma(WHO type 3) in 8 patients. The follow up period ranged from 30 months to 95 months with a median of 56 months. Follow up was possible in all patients. Results:Response to concurrent chemoradiation therapy was a complete response in all patients. Patterns of failure were as follows:local recurrence in only one patient(5.6%) and distant metastases in three patients with N3 diseases(16.7%). The overall 5 year survival rates were 88.5%, the 5 year disease free survival rate was 77% and these were very good results. There were no significant differences in the local control and survival rates between the clinical stages and pathologic types. Conclusion:The outcome of the nasopharyngeal carcinoma treated with concurrent chemoradiotherapy was very good, even though most of the patients(15/18=83.3%) were in stage III and IV diseases. We concluded that concurrrent chemoradiotherapy in nasopharyngeal carcinoma showed the good local control and survival rates without significant complications. In the patients with N3 disease, we have to consider the more effective and strong chemotherapeutic regimens to prevent distant metastases.

Predictors for Amputation in Patients with Diabetic Foot Wound

  • Kim, Se-Young;Kim, Tae Hoon;Choi, Jun-Young;Kwon, Yu-Jin;Choi, Dong Hui;Kim, Ki Chun;Kim, Min Ji;Hwang, Ho Kyung;Lee, Kyung-Bok
    • Vascular Specialist International
    • /
    • v.34 no.4
    • /
    • pp.109-116
    • /
    • 2018
  • Purpose: Diabetic foot wound (DFW) is known as a major contributor of nontraumatic lower extremity amputation. We aimed to evaluate overall amputation rates and risk factors for amputation in patients with DFW. Materials and Methods: From January 2014 to December 2017, 141 patients with DFW were enrolled. We determined rates and risk factors of major amputation in DFW and in DFW with peripheral arterial occlusive disease (PAOD). In addition, we investigated rates and predictors for amputation in diabetic foot ulcer (DFU). Results: The overall rate of major amputation was 26.2% in patients with DFW. Among 141 DFWs, 76 patients (53.9%) had PAOD and 29 patients (38.2%) of 76 DFWs with PAOD underwent major amputation. Wound state according to Wagner classification, congestive heart failure, leukocytosis, dementia, and PAOD were the significant risk factors for major amputation. In DFW with PAOD, Wagner classification grades and leukocytosis were the predictors for major amputation. In addition, amputation was performed for 28 patients (38.4%) while major amputation was performed for 5 patients (6.8%) of 73 DFUs. Only the presence of osteomyelitis (OM) showed significant difference for amputation in DFU. Conclusion: This study represented that approximately a quarter of DFWs underwent major amputation. Moreover, over half of DFW patients had PAOD and about 38.2% of them underwent major amputation. Wound state and PAOD was major predictors for major amputation in DFW. Systemic factors, such as CHF, leukocytosis, and dementia were identified as risk factors for major amputation. In terms of DFU, 38.4% underwent amputation and the presence of OM was a determinant for amputation.